Oroflurb (Flurbiprofen)

Flurbiprofen, the active ingredient in Oroflurb, is a non‑steroidal anti‑inflammatory drug presented as an oral tablet for oral use. It is employed to relieve pain and reduce inflammation in musculoskeletal conditions and postoperative settings.

GNH USA supplies Oroflurb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Flurbiprofen is an NSAID that alleviates pain and inflammation across several musculoskeletal and postoperative conditions.

- Rheumatoid arthritis: reduces joint pain, swelling and stiffness. - Osteoarthritis: improves mobility by decreasing cartilage‑related inflammation. - Acute postoperative pain: provides short‑term analgesia after surgical procedures. - Dysmenorrhea: eases menstrual‑related cramping and discomfort. - Musculoskeletal sprains and strains: diminishes localized pain and swelling.

Flurbiprofen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or pruritus. - Elevated liver enzymes. - Mild renal function changes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe renal impairment or acute kidney injury. - Hepatic failure or hepatitis. - Life‑threatening skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis). - Anaphylactic shock. - Cardiovascular thrombotic events (myocardial infarction, stroke).

When prescribing Flurbiprofen, clinicians should consider several safety measures.

- Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Monitor renal function: use caution in those with chronic kidney disease or dehydration. - Evaluate hepatic status: check liver enzymes before and during therapy. - Use the lowest effective dose for the shortest duration needed. - Avoid in patients with known hypersensitivity to flurbiprofen or other NSAIDs. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Flurbiprofen can alter the activity of several concomitant medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Corticosteroids: synergistic ulcerogenic effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible reduction in renal function. - Selective serotonin reuptake inhibitors (SSRIs): modestly increased bleeding tendency. - Methotrexate: potential for elevated plasma levels and toxicity.